PMPnow Program Director attends CDC Overdose Data to Action Conference

The CDC, in conjunction with ASTHO, held the “Overdose Data to Action” (OD2A) meeting June 7-9, 2023 in Atlanta, GA. The attendees at this conference were from the CDA, ASTHO, state departments of public health, local and Indian Territory health departments, Prescription Drug Monitoring Programs as well as other grant recipients from the CDC/ASTHO programs. Jen Erickson, MHA, MS, PMPnow Program Director for the ILPMP attended this meeting. Jen and Jackie DeNardo, RHIA from the ILPMP developed a Poster Presentation – Integration in Illinois. During the scheduled poster session attendees were able to view and discuss the posters with the presenters. In addition to the scheduled session, the posters were displayed in the major walkways for the two day conference where the attendees could view at anytime.

Overdose Data to Action (OD2A) supports jurisdictions in collecting high quality, comprehensive, and timely data on nonfatal and fatal overdoses and in using those data to inform prevention and response efforts. OD2A focuses on understanding and tracking the complex and changing nature of the drug overdose epidemic and highlights the need for seamless integration of data into prevention strategies. Included as part of these grant programs are opportunities such as this conference for awardees to learn from each other and share the successes of their representatives through these grant funds.

A new nasal spray to reverse fentanyl and other opioid overdoses gets FDA approval

More Information

Amendments to 77 Ill. Adm. Code 2081 - Adopted

Effective 7/7/2023, amendments to 77 Illinois Administrative Code 2081 have been adopted. See published Rules in the July 21 version of the Illinois Register.

University of Illinois Chicago College of Pharmacy to Offer Free Opioid Analgesic REMS CE

FREE Continuing Education Programs for Healthcare Providers, provided through UIC – Illinois ADVANCE

15-20 minute Academic Detailing Virtual Visits (Each program approved for 0.5 contact hours. CME, CNE, CPE)

Meets DEA requirements for opioid education
Fully compliant with the Opioid Analgesic Risk Evaluation and Mitigation Strategy (REMS) education requirement issued by the FDA.

More Information

Educational Resources

NEW Webinar: Continuing Medical Education

Benefits of a Designee

Webinar

Describe the ILPMP program and registration process

Explain how a prescriber can assign a designee

Identify the capabilities and responsibilities of a prescriber and designee within the ILPMP

Discuss the importance and benefits of assigning designee(s)

1.0 contact hour CME

ILPMP.ORG & PMPnow Monthly Data

Contact Information

If you have questions about the information that appears in this update or suggestions for future content, please email dhs.pmp@illinois.gov. Visit www.ilpmp.org for more information.

The Illinois Prescription Monitoring Program (ILPMP) is an electronic database that collects, tracks, and stores reported dispensing data on Schedule II-V controlled substances, selected drugs of interest, and other health information. The Illinois Department of Human Services oversees the ILPMP, authorized by the Illinois Controlled Substances Act (720 ILCS 570/316). The ILPMP adheres to HIPAA and all access, disclosure, and confidentiality provisions of Illinois Law.